Loading
NASDAQConsumer DefensiveHousehold & Personal Products
Latest quote
$0.8251
−$0.0111 · -1.33%
Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing its unique Active Stress Defense™ technology suite. Through this proprietary system, Solesence brings innovative beauty solutions to the market that provide effective environmental protection.
Regular session
$0.8251
−$0.0111 · -1.33%
Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing its unique Active Stress Defense™ technology suite. Through this proprietary system, Solesence brings innovative beauty solutions to the market that provide effective environmental protection.
Day range
Current $0.8251
52-week range
Current $0.8251
Historical prices · Market data may be delayed.
GoAI Score
Hold
Valuation
75
Undervalued
Sentiment
50
Mixed
Risk
77
High Risk
Momentum
19
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing its unique Active Stress Defense™ technology suite. Through this proprietary system, Solesence brings innovative beauty solutions to the market that provide effective environmental protection.
Day range
Current $0.8251
52-week range
Current $0.8251
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 62.06M USD | 52.35M USD | 37.3M USD | 37.32M USD | 29.48M USD |
| Cost of goods sold | 46.04M USD | 36.16M USD | 29.47M USD | 28.96M USD | 20.79M USD |
| Gross profit | 16.03M USD | 16.19M USD | 7.83M USD | 8.36M USD | 8.69M USD |
| Research and development | 4.08M USD | 3.84M USD | 3.84M USD | 3.04M USD | 2.24M USD |
| Selling, general, and administrative | 10.38M USD | 7.22M USD | 7.53M USD | 7.58M USD | 3.9M USD |
| Operating expenses | 14.46M USD | 11.06M USD | 11.37M USD | 10.62M USD | 6.13M USD |
| Interest expense | 931K USD | 670K USD | 838K USD | 382K USD | 1.15M USD |
| Depreciation and amortization | 897K USD | 928K USD | 742K USD | 567K USD | 454K USD |
| Operating income | 1.57M USD | 5.13M USD | −3.55M USD | −2.26M USD | 2.56M USD |
| Net income | 1.79M USD | 4.24M USD | −4.39M USD | −2.62M USD | 2.32M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
iShares Micro-Cap ETFIWCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
